Fetal Stem Cell transplant has demonstrated positive results in the treatment of Rheumatoid Arthritis. You know you need FSC transplant when the patient goes through the following symptoms:
- Resistance to normal treatment
- Ineffective drug therapy – like cytostatics and glucocorticoids
- Significant decrease in functional capacity of the joints
- Trophic disruptions in the musculoskeletal system
- Significant variations in immunologic/hemopoetic parameters
Mesodermal, endodermal and ectodermal fetal stem cells are often used in patients with seronegative and seropositive arthritis of activity grades I – III and those with functional insufficiency of the joints of grades I-III.
Within days of the transplantation, patients begin to see improvements – including reducing weakness, improved motion, normalized sleep and better appetite.
Within the first three months, there is a reduction of inflammatory process activity. There is a visible reduction in joint tenderness, morning sickness and oedema.
It has been observed that in 85% of cases, patients have been able to stay without glucocorticoids and non-steroidal inflammatory drugs. X-ray data shows no progression of joint damage in 72% of patients.
With the treatment, more than 80% of patients have been able to achieve a better quality of life along with remission which lasted anywhere between six months to three years.